SeaStar Medical is trading at $3.92, up +10.11%, as broader market sentiment supports risk appetite.
- The S&P 500 and Nasdaq are higher, with cooler inflation data bolstering risk appetite.
- No clear company-specific catalyst has been identified. On September 29, SeaStar Medical announced its chief medical officer will present at a pediatric therapy conference; the announcement does not establish a direct reason for the share move.
- Healthcare is down 1.33%, so sector performance does not explain the gain.